Port Wine Stains
8
0
0
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
12.5%
1 terminated out of 8 trials
83.3%
-3.2% vs benchmark
0%
0 trials in Phase 3/4
40%
2 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (8)
Rapamycin Dose-Ranging Efficacy Study in Port Wine Stains
Enhanced Efficacy Through Optimization of Hemoporfin-Photodynamic Therapy Parameters in Port-Wine Stains
Maximizing Laser Therapy Success for Port-Wine Birthmarks in Pediatric Patients
Lip Reduction Surgery for Port-wine Macrocheilia
Combined Photodynamic and Pulsed Dye Laser Treatment of Port Wine Stains
Pulsed Dye Laser Treatment of Port Wine Stain Birthmarks: Comparison of 577 nm Versus 595 nm Wavelengths
The Effects of Aldara as an Adjunct to Laser Treatment
Port Wine Stains Treatment Matrix RF Study